Autopsy report · NCT05035862

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

“The study terminated due to funding ending.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 9 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Emory University

Sponsor type

University, hospital or other

Conditions

Asthma

Interventions

Albuterol Sulfate; Interferon gamma-primed mesenchymal stromal cells (MSCs); Prednisone

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction
  “funding for the study was terminated” (94% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (94% match in meaning)
• Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
  “Funding has been terminated for this study.” (91% match in meaning)
• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (90% match in meaning)
• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.